KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation

J Clin Invest. 2011 Feb;121(2):752-68. doi: 10.1172/JCI44185. Epub 2011 Jan 18.

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV; also known as HHV8) is the causative agent of two B cell tumors, multicentric Castleman disease (MCD) and primary effusion lymphoma (PEL). However, little is known about the nature of the specific B cell subtype(s) most susceptible to infection. Identifying these cells would provide direct insight into KSHV transmission and virus-induced transformation. To identify this subset and to determine whether infection alters its cellular phenotype, we exposed human tonsillar cells to KSHV and characterized infected cells using high-throughput multispectral imaging flow cytometry (MIFC). Stable expression of the virally encoded latency-associated nuclear antigen (LANA), a marker of latent KSHV infection, was observed predominantly in cells expressing the l light chain of the B cell receptor. These LANA+ B cells proliferated and exhibited similarities to the cells characteristic of MCD (IgMl-expressing plasmablasts), including blasting morphology with elevated expression of Ki67, variable expression of CD27, and high levels of IgM and IL-6 receptor. Furthermore, the proportion of infected cells showing a blasting phenotype increased upon addition of exogenous IL-6. Our data lead us to propose that oral transmission of KSHV involves the latent infection of a subset of tonsillar IgMl-expressing B cells, which then proliferate as they acquire the plasmablast phenotype characteristic of MCD.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antigens, Viral / immunology
  • B-Lymphocytes / cytology
  • B-Lymphocytes / immunology*
  • Castleman Disease / immunology
  • Castleman Disease / pathology
  • Castleman Disease / virology
  • Cell Differentiation / immunology*
  • Cell Proliferation*
  • Cells, Cultured
  • Disease Transmission, Infectious
  • Genome, Viral
  • Herpesvirus 8, Human / genetics
  • Herpesvirus 8, Human / immunology*
  • Herpesvirus 8, Human / pathogenicity
  • Humans
  • Lymphoma, Primary Effusion / immunology
  • Lymphoma, Primary Effusion / pathology
  • Lymphoma, Primary Effusion / virology
  • Nuclear Proteins / immunology
  • Palatine Tonsil / cytology*
  • Palatine Tonsil / immunology
  • Plasma Cells / cytology
  • Plasma Cells / immunology*

Substances

  • Antigens, Viral
  • Nuclear Proteins
  • latency-associated nuclear antigen

Supplementary concepts

  • Multi-centric Castleman's Disease